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869-1 Heart Failure With Normal Ejection Fraction: Lack of  
Relationship Between Doppler indices of Diastolic 
Function and LV Pressure Transients 
Gerard P. Aurioemma. Michael R. Zile, William H. Gaasch, University of Massachusetts 
Medical School, Worcester, Massachusetts, Lahey C/inic, Burlington, Massachusetts. 
Background: Doppler indices of diastolic function are thought o be useful in the assess- 
ment of the physiologic properties of the diastolic left ventricle, but few data validate their 
use in patients with heart failure (CHF) and normal ejection fraction (EF). Accordingly, the 
purpose of this study was to determine how Doppler indices perform in a series of 
patients with definite diastolic heart failure: CHF and EF exceeding 50%. Methods: Dop- 
pler indices: E, A, E/A ratio, E deceleration time (DT),and isovolumic relaxation time 
(IVRT) were recorded during cardiac catbetedzation (micromanometer: LV end diastolic 
pressure [LVEDP] and the time constant of isovolumic relaxation, tau) in 45 pts (mean 
age 57+ 7) with clinical CHF, evidence of LV hypertrophy, and normal EF. Reeulta: There 
was a significant positive correlation between tau and LVEDP, r=0.72, p<0.006. However, 
a relationship between tau and IVRT could only be discerned when patients were 
grouped separately by LVEDP. Despite the fact that one or more Doppler abnormalities 
was present in each patient, no simple relationship existed between Doppler parameters 
and LVEDP or tau (see Table). Summary/Conclusion: In CHF patients with normal EF 
(diastolic heart failure), Doppler indices of diastolic function do not correlate with either 
LVEDP or tau. Such limited sensitivity of these Doppler parameters is likely due to the 
multiplicity of factors (unstable bemodynamic loads, transmitral pressure gradients, etc.) 
influencing these indices. 
r values relating Doppler and pressure indices of diastolic function 
E velocity E/A ratio DT IVRT 
tau 0.08 0.24 0.01 0.15 
LVEDP 0.01 0.04 0.04 0.16 
2:15 p.m. 
869-2 Racial Paradox in Congestive Heart Failure Survival in 
Patients With Normal Left Ventricular Ejection Fraction 
Padmini Varadaraian, Sanju Sharma, Ramdas G. Pal, VA Medical Center, Loma Linda, 
California, Loma Linda University Loma Linda, California. 
Background: It is generally believed that black and hispanic Americans fare poorly com- 
pared to Caucasians in a variety of cardiovascular disordem. This has been attributed to 
lack of health care access, compliance, and differences in biology. We examined the prog- 
nosis of patients with congestive heart failure by race at our VA medical center where 
access to care and medical management is likely to be similar independent of race. 
Methods: We examined the survival of 2258 patients with a primary hospital discharge 
diagnosis of heart failure between 1990 and 1999. Over a mean follow-up of 786 days 
there were 1535 deaths. The racial composition was 80% caucasians, 10% black and 8% 
hispanic Americans. 963 (43%) patients had normal EF ~55%). Mean age was 7t years 
and 97% were men. Computerized echo and ECG data were used. Survival analysis was 
performed using Kaplan-Meir method and proportional hazards model. 
Results: Survival was similar among the 3 races in the whole cohort and those with 
reduced LVEF. However, in those with normal LVEF, survival was significantly better among 
the Hispanic and the black Americans compared to the caucasians, the 5 year probability 
of survival being 37%, 27% and 21% respectively (p--0.04). Compared to Caucasians, 
black and hispanic Americans were younger (p<0.0001and 0.01), had a lower prevalence 
of atrial fibrillation (p--O.03 and 0.04), but similar degrees of valvular dysfunction. In addi- 
tion, the black Americans had greater degree of LVH (p<0.0001) and lesser prevalence of 
myocardial infarction on the ECG (p--0.01) compared to caucasians. The effect of race on 
survival persisted after correcting for the above confounders (p=0.03). 
Conclusions: 1)Black Amercans with diastolic heart failure are younger and have greater 
degrees of LVH compared to caucasians. 2)Hispanic and black Americans have a betler 
diastolic heart failure prognosis compared to caucasians after correcting for other con- 
founders 
2:30 p.m. 
869-3 Are Racial Differences in the Long-Term Prognosis of 
Systolic Heart Failure Independent of Differences in 
Etiology? 
Kevin L. Thomas. Mark East, Robed Turtle, Linda Shaw, Judy Battle, Eric Paterson, 
Christopher O'Connor, Duke University Medical Center, Durham, North Carolina. 
Background: 
Prior studies have shown that African-Americans (AA) have worse long-term prognoses 
than whites with systolic heart failure. However, the reasons for these differences are 
unclear. We sought to determine if racial differences in the long-term mortality of patients 
with systolic heart failure could be explained by differences in ischemic etiology. 
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Methods: 
Prospectively collected data on 1774 (26% black) patients with Class II-IV symptoms and 
systolic dysfunction (EF<40%) were identified in the Duke Databank of Cardiovascular 
Disease between 1986-1999. Adjusted survival comparisons were performed using Cox 
proportional hazards models. 
Results: 
AA patients with heart failure were younger (median age 56 vs. 63; p<0.01), more often 
female (49% vs. 33%; p<0.01), diabetic (37% vs. 31%; p=0.02), hypertensive (75% vs 
56%; p<0.01 ), and had a $3 gallop (37% vs. 29%; p<O.01 ). AA patients were less likely 
to have significant coronary disease by angiography (41% vs. 69%; p<0.01), prior MI 
(21% vs. 41%; p<0.01), or prior revascularization with PTCA (6% vs. 14%; p<0.01) or 
CABG (4% vs. 16%; p<0.01). There were no significant differences in degree of symp- 
toms based on NYHA class. Ischemic etiology was associated with a 50% increase in 
mortality risk (HR 1,50; 95% CI 1.28-1.75). However, after adjusting for age, gender, 
NYHA class, diabetes, hypertension, peripheral vascular disease, renal disease, $3 gal- 
lop and ischemia, race was not an independent predictor of mortality (p=0.31). 
Conclusion: 
Although previous studies report racial differences in the long-term mortality of patients 
with systolic heart failure, we found no racial differences in the long-term mortality risk of 
patients with systolic heart failure after adjusting for clinical differences and iscbemia. 
2:45 p.m. 
869-4 Body Composition and Prognosis in Chronic Systolic 
Heart Failure: The Obesity Paradox 
Carl J. Lavia, Ahmed F. Osman, Richard V. Milani, Mandeep R. Mehre, OchsnerMedical 
Institutions, New Orleans, Louisiana. 
Introduction: Obesity impairs systolic and diastolic function and is associated with 
increased congestive heart failure (CHF) prevalence; yet low body weight has been 
associated with worse prognosis in chronic CHF patients (pts). We sought to determine 
the impact of body composition on clinical outcomes in chronic CHF pts. 
Methods: We assessed the impact of body composition on major clinical events in 209 
consecutive CHF pts (age 54±10, 81% male, NYHA class 2.4±0.6, ejection fraction 
23¢13%) followed for 18.5±11.5 months, by evaluating quartiles of body mass indices 
(BMI), % body fat as determined by the sum of the skinfold method, and lean body 
weight. 
Results: There were 28 major events (13 deaths, 15 transplants). Pts in the lowest quar- 
tile had significantly greater clinical events than those in the highest quartile of BMI and 
% body fat (p=0.03 for both) (Figure). Pts with the lowest lean weights had significantly 
greater events (p=0.02) than those in the second and third quartiles (but not when com- 
pared with the fourth quartile). In fact, a high % body fat was associated with greater 
event-free survival in both univariate (p=0.02) and multivariate (p=0.03) analyses. 
Conclusion: Obesity may be a CHF risk factor, but this study demonstrates a significant 
inverse relationship between indices of obesity, especially BMI and % body fat, with sub- 
sequent clinical outcomes. This paradox may be related to a heightened catabolic state 
often associated with lower lean body weight in chronic systolic heart failure. 
3:00 p.m. 
869-5 Acute Subcutaneous BNP Administration in Human 
Heart Failure Enhances Diastolic Function and Fi l l ing 
Pressures as Assessed by Doppler Echocardiography 
and Plasma ANP 
Home H. Chen. John C. Bumett, Jr., Lynda J. Nordstrom, Margaret M. Redfield, Mayo 
Clinic and Foundation, Rochester, Minnesota. 
Background: In experimental heart failure (HF), brain natriuretic peptide (BNP) reduces 
preload and has direct lusitropic properties while increasing cardiac output (CO). The 
need for intravenous therapy has limited the use of BNP in humans with chronic HF. The 
objective of the current study was to assess the effects of subcutaneous (SQ) administra- 
tion of BNP (Scios,CA) on diastolic function and filling pressures as assessed by Doppler 
echocardiography and plasma ANP in humans with NYHA class II-III HF (n=8). 
Methods: The dose of SQ BNP was 10 p.g/Kg. CO was measured by Echo Doppler. 
Diastolic assessment included mitral early to late filling velocity ratio (F/A) and decelera- 
tion time before and with Valsalva and the pulmonary venous systolic to diastolic flow 
velocity ratio and Doppler tissue imaging. Diastolic function was classified according to 
increasing severity and filling pressures as: Abnormal relaxation (Grade I); Pseudonor- 
real (Grade II) or Restrictive (Grade III). Doppler and plasma ANP were measured before 
and after SQ BNP. Doppler diastolic assessment was possible in 5 of the 8 patients (atrial 
fibrillation in other 3). 
Reeults: (* p<0.05 vs before BNP). With SQ BNP, CO increased (4.8± 0.4 to 6.4+ 0.5 I/ 
rain*) and systolic blood pressure decreased (125+ 5 to 104+ 3 mmHg*) without a 
change in heart rate. Plasma BNP (167± 115 to 830~ 470 pg/ml*) and cGMP (4± 2 to 14± 
4 pmol/ml*) increased. Plasma ANP decreased (261+ 90 to 16t± 60 pg/mP). The 
changes in the Doppler patterns were consistent with decreases in filling pressures 
(restrictive or pseudonormal to abnormal relaxation, n=3) and improvement in relaxation 
(shortening of deceleration time without increased E/A ratio in patients with abnormal 
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relaxation prior to SQ BNP, n=2). 
Conclusion: Acute SQ BNP reduced cardiac filling pressures and improved lusltropic 
function as evidenced by the changes in the Doppler patterns and the decrease in 
plasma ANP. This investigation supports the conclusion that SQ BNP is an effective 
treatment strategy for this lusltropic hormone and that plasma ANP may serve as a 
serum marker for cardiac filling pressures during the administration of BNP. 
3:15 p.m. 
869-6 Epldemlology of Systolic and Diastolic Dysfunction 
Heart Failure In 3,471 Urban PaUenta 
Akshav K. Khandelwal, John E. McKinnon, Heather J. Shenkman, Vijayamalini Pampati, 
David Nod, Scott Kaatz, Keisha R. Sandberg, Peter A. McCullough, Henry Ford Hospital, 
Detroit, Michigan, University of Missouri-Kansas City School of Medicine, Truman 
Medical Center, Kansas City, Missouri. 
BACKGROUND: We sought to describe congestive heart failure (CHF) in an urban set- 
ring with respect systolic dysfunction (SYS-D) and diastolic dysfunction (DIA-D) in terms 
of age, sex, race, and echo parameters, and survival. 
METHODS: Data were abstracted from the Resource Utilization Among Congestive 
Heart Failure Study, which identified 29,686 CHF patients from a large urban mixed- 
model managed care organization from 1989 to 1999. A target population of 3,471 had 
clinical data taken from automated sources during the first year of diagnosis. We defined 
DIA-D as the presence of CHF with an ejection fraction (EF) of _> 45%, Survival was ana- 
lyzed by Cox regression methods. 
RESULTS: Among the CHF population, 52.2% had DIA-D. A total of 751 men (43.6%) 
and 1,060 women (60.6%), p<0.OOl, 773 whites (54.1%) and 986 blacks (51.2%), p > 
0.05, had DIA-D. Prevalence of DIA-D trended with age, from 46.4% <45 years to 58.7% 
85+ years (p<0.001 for trend). Mean EF was 55.66 vs. 27.96, left ventricular end systolic 
diameter was 3.11 vs. 4.74 cm, and left atdal/aortic outlet ratio was 1.28 vs. 1.38 for DIA- 
D and SYS-D, respectively (p<O.001 for both). Annual age-adjusted mortality was t 1.2% 
and 13.0% for DIA-D and SYS-D, respectively (see figure) (p<0.001). 
CONCLUSIONS: A majority of urban CHF patients including equal proportions of blacks 
and whites have DIA-D and enjoy a slightly better age-adjusfed survival than their coun- 
terparts with SYS-D. 
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1204-141 Slmvastatln Preserves Myocardial Perfuaion and 
Permeability in Experimental Hypercholestarolemia 
Independent of Lipid Lowering 
Piero O. Bonetti, Stephanie H. Wilson, Martin Roddguez-Porcel, David R. Holmes, Jr., 
Lilach O, Lerman, Amir Lerrnan, Division of Cardiovascular Diseases and Division of 
Hypertension, Mayo Clinic, Rochester, Minnesota. 
Background: Experimental Hypercholesterolemia (HC) leads to endothelial dysfunction, 
which is charactedzed by impaired endothelium dependent vasorelaxation and increased 
vascular permeability. Statins have been shown to preserve endothelial function in HC 
not only by cholesterol Iowedng but also by direct lipid-lowering-independent mecha- 
nisms. However, the impact of these effects upon myocardial perfusion (MP) and vascu- 
lar permeability is still unknown. 
Methods: Pigs were randomized to 3 experimental groups: normal diet (N; n=6), high 
cholesterol diet (HC; n=6) and HC diet plus simvastatin (HC+S; n=6) for 12 weeks. Elec- 
tron beam computed tomogrephy studies of the heart were performed before and during 
intravenous infusion of adenosine, and MP and microvascular permeability index (PI) 
were measured in vivo. 
Results: Total and LDL-cholesterol were similarly and significantly increased in the HC 
and HC+S group compared to N. Basal MP was similar in all groups, as was basal PI. 
The changes of MP and PI in response to adenosine are shown in the figure below. 
Conclusion: The current study demonstrates that the impairment of MP and the increase 
in PI in response to cardiac stress associated with experimental HC are prevented by 
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simvastatin therapy in the absence of any lipid-lowering effect. This study suggests a role 
for statins for preservation of myocardial perfusion in pathophysiological states associ- 
ated with coronary endothelial dysfunction. 
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1204-142 Effect of Drug-Induced Hypothyroidism on Cardiac 
Function of Mice Expressing a Troponin T Mutation 
Associated With Familial Hypertrophic Cardlomyopathy 
Biosm C. Knollmann. Todd E. Miller, Fatima DeFreltas, Nell J. Weissman, James D. 
Potter, Georgetown University School of Medicine, Washington, DisL of Columbia, 
University of Miami School of Medicine, Miami, Florida. 
The cardiac phenotype of transgenic mice expressing the FHC-linked Troponin T (TnT- 
179N) mutation is characterized by increased myofilament Ca2+-sensltivity, left-ventricu- 
lar hypercontractility, PR prolongation on ECG, and cardiac dysfunction in response to 
inotropic stimulation. Here we examine the effect of drug-induced hypothyroidism in this 
model. Methods: 179N transgenic mice and non-transgenic Ilttermatas (Non-Tg) were 
fed a diet containing 0.15% 5-propyl-2-tbiouracil (PTU) to induce hypothyroidism, which 
causes an isoform switch from (~- to ~-myosin heavy chain (MHC). This strategy is pre- 
dicted to suppress the transgene expression driven by the c(-MHC promoter. Results: 
After 8 weeks PTU treatment, all mice had clear evidence for hypothyroidism (hair loss, 
bradycardia (275 b/min vs. 400 b/rain, p<.01), PR prolongation on ECG (47rns vs. 40 ms, 
p<.05), prolonged isovolumic relaxation time on Doppler (26ms vs. 16ms, p<.05). ~-MHC 
mRNA was significantly increased, and transgenic TnT-179N mRNA was barely detect- 
able by RT-PCR. Endogenous mouse TnT mRNA and protein was not affected. Trens- 
genic TnT-179N protein was undetectable. Myofilament Ca-sensitivity of PTU-treatad 
179N mice was not significantly different from non-transgenic Iittermatas. PTU treatment 
also abolished all differences in contractile parameters between 179N mice and non- 
transgenic littermates measured by echocardiography, Doppler, and isovolumic heart 
experiments (LV fractional shortening of 179N vs. Non-Tg: Control diet: 42±2% vs. 
31±1%, n= 11, p<0.001; PTU diet: 31±2% vs. 32±2%, n=11, p=0.86). Although PTU 
treatment itself prolonged the PR interval, the PR interval remained significantly longer in 
179N mice, both in surface ECG and isolated heart expedments. Conclusion: PTU treat- 
ment resulted in transcriptional downregulation of transgene expression and reversed 
most, but not all effects of cardiac-targeted transgenic protein expression. 
1204-143 Mesenchymal Stem Cell Transplantation In the 
Repertused or Nonreperfused Myocardial Infarction 
Scar Tissues 
Tae-Jin Youn. Bo-Ra Sohn, Hainan Piao, Jin-Sook Kwon, So-Young Choi, Dong-Woon 
Kim, Young-Gyu Kim, Myeong-Chan Cho, College of Medicine, Chungbuk National 
Universi~ Cheongju, South Korea. 
Background: Mesencbymai stem cells (marrow stromal cells, MSCs) have myogenic 
potentials and transplantation of MSCs is considered to be a novel therapeutic approach 
for post-myocardial infarction (MI) heart failure. We tested whether transplanted MSCs 
could be implanted and subsequently survived in the reperfused or non-reperfused MI 
scar tissues in rats. 
Methods and Results: Female Spregue-Dawley rats were randomly assigned to one of 
three groups: group 1, 45-minute left coronary artery ligation followed by reperfusion 
(early reperfusion with myocardial salvage); group 2, 4-hour left coronary artery ligation 
followed by reperfusion (late reperfusion without myocardial salvage); and group 3, per- 
manent left coronary artery ligation (non-reperfused MI). MSCs from adult rats were cul- 
tured, treated with 5-azacytidine (5-aza, 10 I~mol/L) or not and labeled with 4',6- 
diamidino-2-phenylindole (DAPI) for 80 minutes before transplantation. At 1 week after 
MI, cultured MSCs (lx106 cells), 5-aza-treatad MSCs (lx10 s cells), and medium (control) 
were autologously transplanted into the eady- and lata-reperfused and non-reperfused 
MI scar tissues (n=5, each). At 1 week after transplantation, numerous scattered DAPI- 
labeled cells were detected in early-reperfused infarct tissues irrespective of 5-aza treat- 
ment, However, in late-reperfused and non-reperfused infarct tissues, only scanty DAPI- 
positive cells were identified, 
Conclusion: Both 5-aza untreated and treated MSCs could be transplanted successfully 
and viable until 1 week in early-reperfused infarct tissues, However, in late-reperfused 
and non-repel-fused infarct tissues, transplanted MSCs could not survive, Our results 
implicate that early restoration of blood flow and salvage of myocardium is crucial for the 
fate of transplanted MSCs after MI. 
1204-144 Requirements for Transplanted Skeletal Cells to 
Function Electrically Within Ventricular Myocardium 
Robin M. Shaw. Randall J. Lee, UCSF, San Francisco, California. 
BACKGROUND: Skeletal myocyta transplantation into diseased ventricle is suggested 
as s future therapy for patients with infarcted, non-regenerating myocardium. However 
despite initial clinical success, there is little evidence that implanted skeletal cells can 
communicate lectrically with each other, or with surrounding myocerdium. We assessed 
the electrical requirements for skeletal cells to communicate with each other and with 
ventdcular myocytas. 
METHODS: Theoretical strands were developed composed of sophisticated mathemati- 
